Apellis Pharmaceuticals (APLS) PT Raised to $80 at Citi
Tweet
Share
E-mailGet Alerts APLS Hot Sheet
Price: $41.03 --0%
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $80.00 (from $37.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Downgrades Workday (WDAY) to Hold
- Marvell (MRVL) PT Raised to $325 at Oppenheimer
- Nomura/Instinet Upgrades Malayan Banking Bhd (MAY:MK) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
